Doxorubicin

Buy now to access the full article, existing subscribers login

Sections available in full article Name, Class of drug, Uses, Administration, Routes of administration, Dosage, Pharmocokinetics, Normal, Precautions, Use with care, Interactions, Adverse reactions, Sources, Publications, Vetstream contributor(s),
Contributors Dr William Brewer Jr DVM DiplACVIM Oncology and Internal Medicine
Dr Laura Garrett DVM DACVIM (Oncology)

Name

  • Doxorubicin.

Class of drug

  • Cytotoxic anthracycline antibiotic.  Chemotherapy: general principles 

Uses

Action

  • DNA intercalation and inhibition of nucleic acid synthesis.
  • Free radical formation.
  • Topoisomerase inhibition.

Indications

  • Lymphosarcoma  Lymphoma  .
  • Hemangiosarcoma.
  • Lymphoma, soft tissue sarcomas (including vaccine associated sarcomas) and mammary carcinomas in the cat.
  • It may be used alone or in combination with other antineoplastic therapies.

Adverse reactions

Effects of overdosage

Extravasation

  • Stop injection, aspirate through needle used for injection. Reported treatment strategies include: application of warm compresses, application of topical DMSO, Dexrazoxane, local injection of corticosteroids and surgical debridement. None of these strategies have proven to be consistently effective.

Other reported reactions

  • Severe vesicant if given perivascularity, therefore should be given through well-placed IV catheter. Damage may be severe enough to require amputation.
  • Anorexia, vomiting, severe leukopenia, thrombocytopenia, hemorrhagic gastroenteritis and nephrotoxicity  Nephrotoxicosis  (in cats if cumulative dosages exceed 100 mg/m2).
  • Allergic reactions have been reported.
  • Dose-dependent cumulative cardiotoxicity in dogs (dilated cardiomyopathy  Heart: dilated cardiomyopathy (DCM)  and congestive heart failure  Congestive heart failure  ). This rarely develops in dogs given a total dose of less than 180-240 mg/m2.
  • Tachycardia and arrhythmias on administration but rarely of clinical significance.

Investigation of adverse reaction

  • Dogs with pre-existing cardiac disease should not be given doxorubicin or given it very cautiously with risks/benefits considered.
  • A complete CBC and platelet count  Hematology: platelet count  should be monitored whenever therapy is given. If the neutrophil count drops below 3x10³/dl or if the platelet count drops below 150x10³/dl, treatment should be suspended. Once the counts have stabilized doxorubicin can then be restarted at the same dose.
  • Monitor renal function in cats during treatment.
  • If hematological toxicity occurs again, or if gastrointestinal toxicity is recurrent the dose should be reduced to 1 mg/kg in the cat (20-25 mg/m2 in the dog).

Treatment

Acute anaphylactic reaction
  • Epinephrine  Epinephrine  , steroids and fluids.

Sample content only, to unlock the full article login or buy now

Loading...